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Background: Adverse events are associated with significant morbidity, mortality and cost in hospitalized patients.
Measuring adverse events is necessary for quality improvement, but current detection methods are inaccurate,
untimely and expensive. The advent of electronic health records and the development of automated methods for
encoding and classifying electronic narrative data, such as natural language processing, offer an opportunity to
identify potentially better methods. The objective of this study is to determine the accuracy of using automated
methods for detecting three highly prevalent adverse events: a) hospital-acquired pneumonia, b) catheter-associated
bloodstream infections, and c) in-hospital falls.
Methods/design: This validation study will be conducted at two large Canadian academic health centres: the McGill
University Health Centre (MUHC) and The Ottawa Hospital (TOH). The study population consists of all medical, surgical
and intensive care unit patients admitted to these centres between 2008 and 2014. An automated detection algorithm
will be developed and validated for each of the three adverse events using electronic data extracted from multiple
clinical databases. A random sample of MUHC patients will be used to develop the automated detection algorithms
(cohort 1, development set). The accuracy of these algorithms will be assessed using chart review as the reference
standard. Then, receiver operating characteristic curves will be used to identify optimal cut points for each of the data
sources. Multivariate logistic regression and the areas under curve (AUC) will be used to identify the optimal
combination of data sources that maximize the accuracy of adverse event detection. The most accurate
algorithms will then be validated on a second random sample of MUHC patients (cohort 1, validation set), and
accuracy will be measured using chart review as the reference standard. The most accurate algorithms validated
at the MUHC will then be applied to TOH data (cohort 2), and their accuracy will be assessed using a reference
standard assessment of the medical chart.
Discussion: There is a need for more accurate, timely and efficient measures of adverse events in acute care hospitals.
This is a critical requirement for evaluating the effectiveness of preventive interventions and for tracking progress in
patient safety through time.
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Adverse events (AEs) are injuries caused by the medical
management rather than the underlying condition of the
patient [1]. AEs are estimated to occur in 2.9%–16.6% of
all acute care hospitalizations, and studies have suggested
that 30%–58% of all AEs are preventable [2-9]. Preventable
AEs are a leading cause of death, resulting in 44,000–
98,000 deaths in acute care hospitals each year [1,3,5,6].
Preventable AEs also represent a sizeable cost to our
fragile economy, with total annual cost being estimated
to range between USD $17 and $29 billion due to lost
income, lost household production, disability, and health
care costs [4]. For these reasons, preventing AEs has been
identified as a high priority worldwide [10,11]. An important
requirement to evaluate the success of preventive measures
is to have access to accurate, timely and efficient methods
for monitoring AE rates. However, at present, there are no
such methods.
Indeed, while manual chart review is the reference stand-
ard in many AE detection studies, it is a time-consuming,
resource-intensive and costly process. As a consequence, it
is an impractical means for the routine detection and mon-
itoring of AEs [12-14]. As for prevalence surveys, they are
very costly to implement. For this reason, they are usually
limited to small cross-sectional samples of at-risk patients
or to selected hospital units. Regarding incident and acci-
dent reports, studies have found that compared to manual
chart review they underestimate the true incidence of AEs
by a factor of about 20 [15,16]. Lastly, while discharge diag-
nostic codes have the advantage of being readily available,
relatively inexpensive, and easy to use, [14,15] prior studies
have found that they generally have low to moderate
sensitivity and positive predictive value for identifying
AEs [17-19]. In addition, in many jurisdictions, discharge
diagnostic codes are not dated with precision. As a conse-
quence, it can be difficult to determine whether a given
code (e.g. pulmonary embolism) represents an event
that occurred before the patient was hospitalized (i.e. a
comorbid condition) or during the actual hospitalization
(i.e. an AE) [20,21]. Moreover, discharge diagnostic codes
usually become available several months after discharge,
which makes them impractical for timely AE detection
and monitoring. In summary, the limitations in existing
methods for measuring AEs have not only curtailed the
ability to conduct continuous quality monitoring in acute
care hospitals but also to pursue important investigational
work on potentially preventable causes of AEs. To move
the field forward, there is a need for more accurate, timely
and efficient methods of AE detection.
With the advent of electronic health records (EHR)
and digital capture of progress notes and other clinical
data—which were paralleled with the development of au-
tomated methods for encoding and classifying electronic
clinical narratives—an exciting opportunity has emergedto identify potentially better methods of AE detection.
Taking advantage of this new opportunity, the purpose of
this study is to determine the accuracy of using automated
algorithms for detecting AEs from EHR data.
Literature review
Pilot work: novel methods of AE detection
With the increasing availability of electronic clinical data,
preliminary investigations have attempted to use a variety
of electronic triggers (e.g. an abnormal laboratory test
result such as an elevated white blood cell count or the
prescription of an antidote drug) as a means to identify
potential cases of AEs. While these methods offer promise
for detecting AEs, the reported sensitivities and positive
predictive values are low, suggesting that many AEs may
go undetected, and that many of the events that are identi-
fied are indeed false positives [13].
More recently, researchers have started to use alterna-
tive and potentially more accurate approaches to AE
detection, such as natural language processing (NLP) of
dictated electronic radiology reports or discharge sum-
maries [22,23]. NLP refers to automated methods for
converting free-text data into computer-understandable
format [24]. NLP techniques have been divided into two
broad categories: symbolic and statistical. Symbolic NLP
techniques use the characteristics of the language (i.e.
semantics, syntax and the relationships among sentences)
to interpret a narrative document to the extent necessary
for encoding it into one of a set of predefined categories
(e.g. positive or negative for pneumonia) [25,26]. As for
statistical NLP techniques, they use the frequency dis-
tribution of words and phrases to automatically classify
a set of narrative documents [27,28].
The results of preliminary studies that have implemented
these NLP techniques are encouraging [29,30]. For instance,
we recently conducted a pilot study to validate the accuracy
of using statistical NLP for identifying cases of deep vein
thrombosis (DVT) and pulmonary embolism (PE) from
free-text electronic narrative radiology reports [31]. This
method was found to be highly effective and accurate. The
statistical NLP model predicting DVT achieved sensitivity
of 0.80 (95% CI: 0.76–0.85), specificity of 0.98 (98% CI:
0.97–0.99) and positive predictive value (PPV) of 0.89
(95% CI: 0.85–0.93). As for the statistical NLP model
predicting PE, sensitivity was 0.79 (95% CI: 0.73–0.85),
specificity 0.99 (95% CI: 0.98–0.99), and PPV was 0.84
(95% CI: 0.75–0.92) [31].
However, narrative data alone may not contain all the
information needed to accurately identify all types of AEs.
For some events, such as hospital-acquired pneumonia
(HAP), it might be necessary to combine the information
from a variety of electronic data sources, including narra-
tive chest x-ray reports, microbiology and laboratory data,
and progress notes to accurately identify positive cases
Rochefort et al. Implementation Science  (2015) 10:5 Page 3 of 9[13]. To move this field forward, as well as to maximize
the accuracy of AE detection, there is a need for com-
prehensive automated AE detection algorithms that in-
tegrate the information from all the available data
sources (e.g. microbiology and laboratory results, free-
text radiology reports and progress notes and electronic
vital signs). The primary objective of this study, and the
original contribution of this research proposal, is to as-
sess the accuracy of using comprehensive automated
algorithms for detecting AEs in acute care hospitals. A
secondary objective of this study is to determine the
external validity of these algorithms.
Methods
Settings
This study will be conducted at two leading Canadian
academic health centres: the McGill University Health
Centre (MUHC) and The Ottawa Hospital (TOH). The
MUHC is composed of five acute care hospitals and has
more than 800 adult beds. It serves a population of 1.7
million people (22% of Quebec’s population), with an an-
nual volume of 735,000 ambulatory visits, 33,300 surgeries,
and 40,000 hospitalizations [32]. TOH is composed of three
campuses serving a community of more than one million
people across the National Capital Region and Eastern
Ontario. It is composed of 1,149 beds, with annual volumes
of more than 1,000,000 ambulatory care visits, 34,000 sur-
geries, and 48,000 patient admissions [33]. TOH was the
first academic health centre in Canada to implement a
research data warehouse as part of its clinical information
system and to pioneer AE detection and monitoring
through new information technologies and the secondary
use of electronic clinical data.
Design and population
The study population will consist of all adult medical,
surgical and intensive care unit patients admitted to the
MUHC and TOH between January 1, 2008 and December
31, 2014. First, a random sample of MUHC patients will
be used to develop baseline automated AE detection
algorithms (cohort 1, development set). These baseline
algorithms will be developed using published definitions
(e.g. National Healthcare Safety Network/Centers for Dis-
ease Control and Prevention (CDC/NHSN) definitions of
nosocomial infections), which will also guide the extrac-
tion of the required data from the various electronic
clinical databases at the MUHC and TOH. Then, the
accuracy of these baseline algorithms will be assessed
in comparison to information contained in the medical
charts. To maximize the accuracy of AE detection, these
algorithms will then be iteratively optimized by varying
the cutoff values for each of the data sources, as well as
the type and the number of data sources included in the
algorithms. The most accurate algorithms will then bevalidated on a distinct random sample of MUHC patients
(cohort 1, validation set). To determine the robustness of
these algorithms and the extent to which they can be
generalized to other acute care settings, the most accur-
ate algorithms developed and validated at the MUHC will
be applied to a random sample of TOH patients (cohort 2),
and a reference standard assessment of the medical chart
will be performed.Data sources and data extraction
Data required to develop the automated algorithms will
be extracted from the MUHC and TOH clinical data ware-
houses and will be linked by unit, patient and hospital ad-
mission date and time. Specifically, data will be extracted
from nine electronic databases, including: 1) laboratory, 2)
microbiology, 3) radiology, 4) vital signs, 5) intensive care
unit, 6) pharmacy, 7) admission, discharge and transfer, 8)
discharge abstracts, and 9) narrative progress notes.Approach
Development of automated AE detection algorithms
For the purpose of this study, three potentially prevent-
able AEs were selected: a) hospital-acquired pneumonias
(HAPs), including ventilator-associated pneumonias (VAPs);
b) central venous catheter-associated blood stream in-
fections (CVC-BSIs); and c) in-hospital falls. These AEs
were selected because they can each result in increased
morbidity, mortality and length of hospital stay, as well
as increased health care expenditures [34-42]. Moreover,
these indicators have high incidence rates compared to
other AEs. HAPs represent one of the most common
nosocomial infections, accounting for 15% of all hospital-
acquired infections and 25% of all ICU-acquired infections
[34-37]. HAPs are estimated to occur at a rate of between
five and ten cases per 1,000 hospital admission, and in
about 8%–28% of patients receiving mechanical ventila-
tion [34,37,43]. Central venous catheters are the single
most important cause of health-care-associated blood-
stream infections, with CVC-BSIs estimated to occur in
2%–6% of all catheterizations [38,39,44]. Between 3%
and 27% of patients will fall at least once during their
hospitalization [40,45,46].
Data from the development set (cohort 1) will be used
to develop three baseline automated AE detection algo-
rithms, one for each of the selected AEs. These baseline
algorithms will be developed by applying the CDC/NHSN
definitions for HAP/VAP [47] and CVC-BSI [42] and the
WHO definition for a fall [48] (Table 1). A positive case of
AE will be defined as any patient whose electronic data
satisfies the CDC/NHSN definitions for HAP/VAP and
CVC-BSI or the WHO definition for a fall (Table 1). Nega-
tive cases will be those patients that are negative on one
or more of these criteria.
Table 1 Data sources and criteria for determining adverse event (AE) occurrence
Adverse event Database Method for
detecting
Criteria assessed >48 h after hospital admission (HAP, CVC-BSI) or
initiation of mechanical ventilation (VAP)
HAP/VAP Radiology NLP A chest radiograph that is suggestive of a) a new, progressive or
persistent infiltrate; b) consolidation; or c) cavitation
Microbiology Query/rule Qualitative and quantitative reports of sputum cultures suggestive
of the presence of HAP or VAP (e.g. Gram stain of respiratory
secretions sample with ≥25 neutrophils and ≤10 squamous epithelial
cells per high power field)
Laboratory Query/rule Evidence of leukopenia (WBC < 4,000/mm3), leukocytosis (WBC > 12,000/mm3)
or abnormal trends in the WBC
Vital signs Query/rule Patient body temperature >38°C or abnormal trends in elevated body
temperatures; Worsening gas exchanges (e.g. O2 desaturations, increased
oxygen requirements, increased ventilator demand [⬆FiO2 of ≥ 0.2 point
or⬆PEEP values of ≥ 3cmH2O compared to previous 48 h and sustained for 48 h)
Progress notes NLP Evidence of altered mental status in patients ≥70 years old
Pharmacy Query/rule Prescription of a new antimicrobial agent covering the micro-organisms most
commonly causing HAP/VAP, duration and timing of antibiotic exposure [49].
CVC-BSI Microbiology Query/rule Blood cultures that are suggestive of the presence of a CVC-BSI. To exclude cases
of secondary BSI, special queries will be constructed to determine if organisms
recovered from blood cultures were also recovered from non-blood cultures
(e.g. sputum, surgical site or urine cultures). CDC/NHSN rules will be followed
to exclude cases of positive blood cultures due to contamination from common
skin commensals
Laboratory Query/rule Evidence of leucopenia (WBC < 4,000/mm3), leukocytosis (WBC > 11,000/mm3)
or abnormal trends in the WBC
Vital signs Query/rule Body temperature >38°C or abnormal trends in elevated body temperatures >48 h
after hospital admission
Pharmacy Query/rule Prescription of an antibiotic covering the micro-organisms most commonly causing
CVC-BSIs, duration and timing of antibiotic exposure [49]
Radiology NLP To define the denominator, the radiology database will be consulted to identify
chest radiograph reports showing the presence of a CVC [50]
Progress notes NLP Progress notes suggestive of the presence of a CVC-BSI
In-hospital fall Progress notes NLP Progress notes suggestive of an in-hospital fall (e.g. ‘patient found on the floor’,
‘patient fell off the bed’)
Radiology NLP Narrative radiology reports that are suggestive of the occurrence of a fall
(e.g. history of fall, s/p fall, syncope). Then, these reports will be scanned for
evidence of soft tissue injuries, long bones, hip, wrist or skull fractures or
traumatic brain injuries
Abbreviations: NLP Natural Language Processing, WBC white blood cell count, HAP hospital-acquired pneumonia, VAP ventilator-associated pneumonia, CVC-BSI
central venous catheter-associated blood stream infections.
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The accuracy of the baseline algorithms will be assessed
using a reference standard assessment of the medical
chart. Charts will be reviewed by trained medical chart
reviewers (MCRs) that will be blind to the patients’ AE
status (i.e. positive vs. negative) as determined by the
automated algorithms. MCRs will use a standardized
computer-based abstraction form that was developed
during our pilot work [31]. To assess inter-rater reli-
ability, a random sample of 10% of the medical charts
will be blindly reviewed by a second MCR, and interclass
correlation coefficients (ICC) will be computed. To ensure
data quality throughout the study, MCRs will undergo
periodic quality assurance monitoring.Optimization of the automated AE detection algorithms
Prior studies have shown that the CDC/NNSH definitions
have limited accuracy for identifying cases of AEs [51-53].
To maximize the accuracy of AE detection, the baseline
algorithms for HAP/VAP and CVC-BSI will be optimized
using four successive steps. Steps 1–3 will use the patient
medical chart as the reference standard, whereas step 4
will estimate the reference standard using latent class
analyses.
Step 1: Receiver operating characteristic (ROC) curves
will be used to identify: a) optimal cut points for defin-
ing the presence of an AE (e.g. using various threshold
values for defining an elevated white blood cell count, an ab-
normal ventilator setting or an elevated body temperature)
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(e.g. requiring a single day with an elevated WBC vs. at least
two consecutive days). In addition, the ROC area under
curve (AUC), along with its 95%CIs, will be used to assess
the accuracy of each data source.
Step 2: Three separate multivariate logistic regression
analyses—one for each AE—will be conducted to assess
the incremental effect in detection accuracy of combin-
ing data sources, using the optimal cut points and meas-
urement windows defined in step 1. Stepwise and backward
procedures will be used to identify data sources that are sig-
nificantly associated with the occurrence of an AE. AUCs
along with their 95%CIs will be used to assess the incre-
mental effect in detection accuracy associated with the
inclusion of a given data source in the regression model.
AUCs across models will be compared using the approach
described by Hanley and McNeill [54]. Data sources not
significantly associated with AE occurrence will be elimi-
nated from the model.
Step 3: The regression models developed in step 2 will
be used to assess the incremental effect in detection ac-
curacy of including patient demographic characteristics
and comorbidities. Indeed, prior studies have found that
older patients with more comorbidities are at higher risk
of experiencing AEs [12]. Patient age, sex, and admission
urgency (elective vs. urgent) and admission type (medical
vs. surgical) will be obtained from the discharge ab-
stract database. Comorbidities will be measured using
the Charlson Comorbidity Index, a weighted index of
17 comorbidities that are associated with an increased
risk of mortality [55]. Comorbidities will be extracted
from discharge summaries and progress notes using a
previously validated NLP system described by Chuang
et al. [56]. Then, patient age and comorbidities will be
entered as continuous variables in the regression models,
whereas patient sex and admission urgency and type will be
included as dichotomous variables. The AUCs of models
containing demographic characteristics and comorbidities
will be compared to that of models not containing these
characteristics [54].
Step 4: The limitations associated with using the patient
medical charts as the reference standard for determining
the true AE status (e.g. omissions, errors) [13] will be ac-
knowledged as these limitations may influence the per-
ceived accuracy of the automated AE detection algorithms
in either direction [57]. As such, the analyses from steps
1–3 will be repeated using latent class analysis to estimate
the reference standard. Latent class analyses will be con-
ducted assuming the conditional dependence of the data
sources [57]. The AUCs of the best performing algorithms
from step 1 to step 3 will then be compared to that of the
best performing models from step 4 [54].
Lastly, the best performing algorithms from the develop-
ment steps will be applied to the validation set (cohort 1)and their performance will be assessed using the AUCs.
AUCs from the validation set will then be compared to
those obtained during the development steps [54]. In each
of the development steps (steps 1–4) and validation steps
estimates of sensitivity, specificity, positive and negative
predictive value, along with their 95% confidence intervals,
will be computed for the best performing algorithms.
External validation of the automated AE detection
algorithms
To assess the robustness and the extent to which the best
performing algorithms developed and validated at the
MUHC can be generalized to other acute care hospitals,
they will be applied to a second cohort (cohort 2) consist-
ing of medical, surgical and intensive care unit patients
admitted to TOH. A reference standard assessment of
the medical chart will then be performed, and the AUCs
obtained from cohort 2 will be compared to those obtained
from the best performing algorithms in cohort 1 to deter-
mine if there are significant differences in the performance
of the algorithms across sites.
Sample size requirements
To maximize efficiency, AE positive patients will be over-
sampled in relation to AE negative patients [58]. To avoid
bias due to seasonal trends, [59,60] each AE positive pa-
tient will be matched with AE negative patients who will
be sampled among those that were admitted on the same
date. In addition, to minimize the costs associated with
performing chart review, all AE negative patients will be
selected so that they are negative for all three AEs accord-
ing to the automated AE detection algorithms.
Assuming an incidence rate of 5.0% for both HAP/VAP
[34,37,43] and CVC-BSIs [38,39,44] and of 7.0% for in-
hospital falls, [40,45] a total of 639 AE positive charts and
3,099 AE negative charts will be reviewed at the MUHC,
using the worst case scenario (see Tables 2 and 3), to gen-
erate a 95% confidence interval width of 0.10 around a
sensitivity estimate of 0.90 that is adjusted for the over-
sampling of AE positive patients [58]. Similar figures will




A considerable amount of time and effort were required
during the first 2 years of the study for extracting, cleaning
and formatting the required data, as well as for meeting
confidentiality and security requirements for data extrac-
tion and use at each site. At present time, we have devel-
oped and validated a statistical NLP model for identifying
narrative radiology reports that are suggestive of the
presence of pneumonia. We are now in the process of
developing the pneumonia detection algorithm using this
Table 2 Sample sizesa required for a 95% confidence interval width of 0.10 around the sensitivity estimate adjusted for the over-sampling of adverse event
(AE) positive patients induced by the study design












No. of AE positive
patients
No. of AE negative
patients
Total no. of patients
sampled
Nosocomial pneumonia (NP) 0.05 0.95 0.85 0.80 0.10290 191 1,980 2,171
0.90 0.10290 94 979 1,073
0.90 0.80 0.07104 237 3,099 3,336
0.90 0.07104 117 1,532 1,649
0.98 0.85 0.80 0.06667 119 1,975 2,094
0.90 0.06667 59 976 1,035
0.90 0.80 0.04545 148 3,111 3,259
0.90 0.04545 73 1,538 1,611
Central venous catheter-associated
blood stream infection (CVC-BSI)
0.05 0.95 0.85 0.80 0.10290 191 1,980 2,171
0.90 0.10290 94 979 1,073
0.90 0.80 0.07104 237 3,099 3,336
0.90 0.07104 117 1,532 1,649
0.98 0.85 0.80 0.06667 119 1,975 2,094
0.90 0.06667 59 976 1,035
0.90 0.80 0.04545 148 3,111 3,259
0.90 0.04545 73 1,538 1,611
In-hospital fall 0.07 0.95 0.85 0.80 0.10290 133 1,379 1,512
0.90 0.10290 66 682 747
0.90 0.80 0.07104 165 2,161 2,327
0.90 0.07104 82 1,068 1,150
0.98 0.85 0.80 0.06667 83 1,376 1,458
0.90 0.06667 41 680 721
0.90 0.80 0.04545 103 2,170 2,273
0.90 0.04545 51 1,073 1,124












Table 3 Calculation for establishing the required sample
size, assuming the worst case scenario for each adverse
event (AE) indicator
Adverse event (AE) indicator Worst case scenarioa
AE positive AE negativeb
Nosocomial pneumonia (NP) 237 3,099
Central venous catheter-associated
blood stream infection (CVC-BSI)
237 3,099
In-hospital fall 165 2,161
Total 639 3,099
Total number of charts to be
reviewed if worst case scenario
3,738
aBased on optimal sample sizes provided in Table 2 (see values in italics). bTo
minimize the costs associated with performing chart review, all AE negative
patients will be selected so that they are negative for all three AEs according
to the automated detection algorithms. As such, 3,099 is the largest number
of AE negative patients required, assuming the worst case scenario.
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tronic sources (e.g. microbiology and laboratory results,
electronic vital signs). The development of the CVC-BSI
algorithm is also underway.Relevance and impact
This study will likely produce more accurate and timely
measures of AEs. Three important contributions of this
study should be emphasized. First, we propose to integrate
several sources of EHR data into comprehensive auto-
mated AE detection algorithms. This approach contrasts
with previous algorithms, [29,30,61-66] which were for
the most part based on a single source of EHR data (e.g.
electronic triggers or narrative radiology reports). Second,
we will attempt to maximize accuracy by optimizing the
automated algorithms, an approach that also departs from
prior studies. Lastly, we will determine if the automated
AE detection algorithms developed in one setting can be
generalized to other similar clinical contexts; a question
that has rarely been addressed in prior investigations.
The measures that will be developed and validated in
this study are likely to have multiple applications. Hospi-
tals could use these measures to assess the incidence rates
of AEs, develop near real-time monitoring systems, evaluate
different interventions aimed at improving patient safety,
track progress in patient safety through time, or benchmark
performance at the local or national levels. In addition, be-
cause these methods are automated, they offer the potential
to rapidly scan large numbers of patient records and EHR
data with minimal human effort, a major gain compared
to using manual chart review. Moreover, because these
methods will be applied to electronic data that have the
advantage of being time and date stamped (e.g. radiology
reports), they can potentially determine the timing of AE
occurrence with relatively high precision; a net improve-
ment compared to using discharge diagnostic codes and akey requirement for determining how antecedent expo-
sures are related to the risk of AE.
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